Elevated aPS/PT IgM levels in APS and RPL populations are strongly associated with adverse pregnancy outcomes (11, 12), and their sensitivity appears to exceed that of aCL and aβ2GPI antibodies (21). The gene discussed is ACLY; the disease is autoimmune polyendocrinopathy.